Naloxone

A μ-opioid receptor antagonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Naloxone on PubChem

EVZIO; NALOXONE HYDROCHLORIDE; NARCAN; NARCANTI; NARCON

Link	Tested on	Impact factor	Notes	Publication date
Dual Targeting of 3CLpro and PLpro of SARS-CoV-2: A Novel Structure-Based Design Approach to treat COVID-19 3CLpro RdRpol Small molecule In silico	in silico		Predicted to bind both the SARS-CoV-2 RNA-dependent RNA polymerase and 3C-like protease.	Dec/10/2020

Link	Publication date
Repurposing FDA-approved drugs against multiple proteins of SARS-CoV-2: An in silico study.	Jul/11/2021
Inhaled [D-Ala2]-Dynorphin 1-6 Prevents Hyperacetylation and Release of High Mobility Group Box 1 in a Mouse Model of Acute Lung Injury.	Sep/27/2021